Skip to content

Neuron

ISSN 1097-4199

36 papers in the library · 2,645 citations · publishing 1999-2026

Papers

Sort Most recent Most cited

The ethical impasse of current consciousness science.

Neuron June 17, 2026 Vincent Taschereau-Dumouchel, Jun Seo Hwang, Hakwan Lau et al.

Rising media attention regarding consciousness in animals, fetuses, organoids, and AI has led to some rather strong statements. Most of these claims are based on "markers" of consciousness that track the general capacity for information processing rather than subjective experience per se. Accordingly, their relevance for theory arbitration may actually be limited.

The neuroscience of advanced meditation: The promise of third wave meditation research.

Neuron May 6, 2026 Matthew D. Sacchet, Jonathan M. Lieberman

Third wave meditation research-the study of advanced meditation-investigates states, stages, and endpoints of meditation practice that emerge with increasing mastery. We review current neuroscientific progress, outline future research directions, and highlight far-reaching implications of this emerging scientific subfield.

Immune-brain plasticity underpins stress and affective behaviors.

Neuron January 7, 2026 Jinsu Lee, Michael A. Wheeler

The lifetime prevalence of mood disorders such as major depressive disorder (MDD) is thought to approach up to 50% of the world's population. Traditionally, research into the mechanisms of these disorders has focused on neurotransmission, but emerging evidence highlights neuroimmune interactions-the molecular signaling between immune and brain cells-as key regulators of brain plasticity,...

Synaptic priming: A framework for pharmacotherapy in depression.

Neuron November 19, 2025 Kyle A Brown, Musa I Ajibola, Gustavo C Medeiros et al. 6 citations

Recent antidepressant drug development focuses on a next generation of drugs to rapidly relieve symptoms. Yet, how ketamine, the prototype rapid-acting antidepressant, maintains symptom relief days after drug elimination, and how repeated doses sustain longer-lasting therapeutic effects, remains unclear. Derived from elements of metaplasticity (synaptic priming), this review discusses a...

The polypharmacology of psychedelics reveals multiple targets for potential therapeutics.

Neuron July 15, 2025 Manish K. Jain, Ryan H. Gumpper, Samuel T. Slocum et al. 42 citations

The classical psychedelics (+)-lysergic acid diethylamide (LSD), psilocybin, and mescaline exert their psychedelic effects via activation of the 5-HT2A serotonin receptor (5-HT2AR). Recent clinical studies have suggested that classical psychedelics may additionally have therapeutic potential for many neuropsychiatric conditions including depression, anxiety, migraine and cluster headaches, drug...

Ketamine rescues anhedonia by cell-type- and input-specific adaptations in the nucleus accumbens.

Neuron May 7, 2025 Federica Lucantonio, Jacob Roeglin, Shuwen Li et al. 24 citations

Ketamine is recognized as a rapid and sustained antidepressant, particularly for major depression unresponsive to conventional treatments. Anhedonia is a common symptom of depression for which ketamine is highly efficacious, but the underlying circuits and synaptic changes are not well understood. Here, we show that the nucleus accumbens (NAc) is essential for ketamine's effect in rescuing...

Breaking through anhedonia: How ketamine reignites the drive for rewards.

Neuron May 7, 2025 Colleen A McClung

In this issue of Neuron, Pignatelli et al.1 find that ketamine reverses stress-induced changes in excitatory synapses in nucleus accumbens D1 dopamine receptor-expressing medium spiny neurons (D1-MSNs) and that these changes are necessary for the treatment of anhedonia-like behavior.

Ketamine induces plasticity in a norepinephrine-astroglial circuit to promote behavioral perseverance.

Neuron February 5, 2025 Marc Duque, Alex B. Chen, Eric Hsu et al. 27 citations

Transient exposure to ketamine can trigger lasting changes in behavior and mood. We found that brief ketamine exposure causes long-term suppression of futility-induced passivity in larval zebrafish, reversing the "giving-up" response that normally occurs when swimming fails to cause forward movement. Whole-brain imaging revealed that ketamine hyperactivates the norepinephrine-astroglia circuit...

Ventral hippocampal parvalbumin interneurons gate the acute anxiolytic action of the serotonergic psychedelic DOI.

Neuron November 20, 2024 Praachi Tiwari, Pasha A. Davoudian, Darshana Kapri et al. 26 citations

There has been a recent renewal of interest in the therapeutic potential of serotonergic psychedelics. Here, we uncover the essential role of ventral hippocampus (vHpc) GABAergic interneurons in the anxiolytic effect evoked by the serotonergic psychedelic 2,5-dimethoxy-4-iodoamphetamine (DOI). Integrating anatomical, pharmacological, and genetic approaches, we show that 5-HT2A receptors in the...

Structural basis of psychedelic LSD recognition at dopamine D1 receptor.

Neuron October 9, 2024 Luyu Fan, Youwen Zhuang, Hongyu Wu et al. 6 citations

Understanding the kinetics of LSD in receptors and subsequent induced signaling is crucial for comprehending both the psychoactive and therapeutic effects of LSD. Despite extensive research on LSD's interactions with serotonin 2A and 2B receptors, its behavior on other targets, including dopamine receptors, has remained elusive. Here, we present cryo-EM structures of LSD/PF6142-bound dopamine...

Ketamine ameliorates post-traumatic social avoidance by erasing the traumatic memory encoded in VTA-innervated BLA engram cells.

Neuron September 25, 2024 Ming Li, Xue-Ke Yang, Jian Yang et al. 30 citations

Erasing traumatic memory during memory reconsolidation is a promising retrieval-extinction strategy for post-traumatic stress disorder (PTSD). Here, we developed an acute social defeat stress (SDS) mouse model with short-term and re-exposure-evoked long-term social avoidance. SDS-associated traumatic memories were identified to be stored in basolateral amygdala (BLA) engram cells. A single...

An integrative, multiscale view on neural theories of consciousness.

Neuron May 15, 2024 Johan F. Storm, P Christiaan Klink, Jaan Aru et al. 108 citations

How is conscious experience related to material brain processes? A variety of theories aiming to answer this age-old question have emerged from the recent surge in consciousness research, and some are now hotly debated. Although most researchers have so far focused on the development and validation of their preferred theory in relative isolation, this article, written by a group of scientists...

Taking consciousness for real: Increasing the ecological validity of the study of conscious vs. unconscious processes.

Neuron May 15, 2024 Liad Mudrik, Rony Hirschhorn, Uri Korisky 15 citations

The study of consciousness has developed well-controlled, rigorous methods for manipulating and measuring consciousness. Yet, in the process, experimental paradigms grew farther away from everyday conscious and unconscious processes, which raises the concern of ecological validity. In this review, we suggest that the field can benefit from adopting a more ecological approach, akin to other...

The neuroscience of lucid dreaming: Past, present, future.

Neuron April 3, 2024 Paul Zerr, Nico Adelhöfer, Martin Dresler

Lucid dreaming allows conscious awareness and control of vivid dream states; however, its rarity and instability make neuroscientific experimentation challenging. Recent advances in wearable neurotechnology, large-scale collaborations, citizen neuroscience, and artificial intelligence increasingly facilitate the decoding of this intriguing phenomenon.

Amyloid induced hyperexcitability in default mode network drives medial temporal hyperactivity and early tau accumulation.

Neuron December 1, 2023 Joseph Giorgio, Jenna N. Adams, A. Maass et al.

In early Alzheimer's disease (AD) β-amyloid (Aβ) deposits throughout association cortex and tau appears in the entorhinal cortex (EC). Why these initially appear in disparate locations is not understood. Using task-based fMRI and multimodal PET imaging, we assess the impact of local AD pathology on network-to-network interactions. We show that AD pathologies flip interactions between the...

20 years of the default mode network: A review and synthesis

Neuron May 10, 2023 Vinod Menon 832 citations

The discovery of the default mode network (DMN) has revolutionized our understanding of the workings of the human brain. Here, I review developments that led to the discovery of the DMN, offer a personal reflection, and consider how our ideas of DMN function have evolved over the past two decades. I summarize literature examining the role of the DMN in self-reference, social cognition, episodic...

THC and CBD: Similarities and differences between siblings.

Neuron February 1, 2023 Nephi Stella

Δ9-tetrahydrocannabinol (THC) and its sibling, cannabidiol (CBD), are produced by the same Cannabis plant and have similar chemical structures but differ dramatically in their mechanisms of action and effects on brain functions. Both THC and CBD exhibit promising therapeutic properties; however, impairments and increased incidence of mental health diseases are associated with acute and chronic...

The costs and benefits of psychedelics on cognition and mood

Neuron January 20, 2023 Ceyda Sayalı, Frederick S. Barrett 40 citations

Anecdotal evidence has indicated that psychedelic substances may acutely enhance creative task performance, although empirical support for this claim is mixed at best. Clinical research has shown that psychedelics might have enduring effects on mood and well-being. However, there is no neurocognitive framework that ties acute changes in cognition to long-term effects in mood. In this review, we...

Signaling snapshots of a serotonin receptor activated by the prototypical psychedelic LSD.

Neuron October 5, 2022 Can Cao, Ximena Barros-Álvarez, Shicheng Zhang et al. 158 citations

Serotonin (5-hydroxytryptamine [5-HT]) 5-HT2-family receptors represent essential targets for lysergic acid diethylamide (LSD) and all other psychedelic drugs. Although the primary psychedelic drug effects are mediated by the 5-HT2A serotonin receptor (HTR2A), the 5-HT2B serotonin receptor (HTR2B) has been used as a model receptor to study the activation mechanisms of psychedelic drugs due to...

Ketamine exerts its sustained antidepressant effects via cell-type-specific regulation of Kcnq2.

Neuron May 1, 2022 J. Lopez, M. Lücken, E. Brivio et al. 78 citations

A single sub-anesthetic dose of ketamine produces a rapid and sustained antidepressant response, yet the molecular mechanisms responsible for this remain unclear. Here, we identified cell-type-specific transcriptional signatures associated with a sustained ketamine response in mice. Most interestingly, we identified the Kcnq2 gene as an important downstream regulator of ketamine action in...

Hippocampal ripples and their coordinated dialogue with the default mode network during recent and remote recollection

Neuron July 16, 2021 Yitzhak Norman, Omri Raccah, Su Liu et al.

SUMMARY Hippocampal ripples are prominent synchronization events generated by hippocampal neuronal assemblies. To date, ripples have been primarily associated with navigational memory in rodents and shortterm episodic recollections in humans. Here, we uncover different profiles of ripple activity in the human hippocampus during the retrieval of recent and remote autobiographical events and...